i
ii
iii
iv
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
Sales or potential sales of our common stock by us or our significant stockholders may cause the market price of our common stock to decline.
We are not restricted from issuing additional shares of common stock, including shares issuable pursuant to securities that are convertible into or exchangeable for, or that represent the right to receive, common stock. As of August 30, 2010, we had 34.7 million shares of common stock outstanding. In addition, as of that date, approximately 6.6 million shares of our common stock were issuable pursuant to outstanding stock options and awards which had not yet vested or which had been previously acquired upon vesting but had not yet been delivered. Additional shares of common stock are also available to be granted under our existing equity plans or may be granted under future equity plans.
In addition, under two registration rights agreements that we entered into with Comverse, Comverse has registration rights with respect to its common stock and preferred stock holdings in Verint. As of August 15, 2010, if it were convertible, the preferred stock could have been converted into approximately 10.2 million shares of our common stock.
Also, for the first time since the beginning of our extended filing delay in March 2006, our directors and certain members of management will now have the ability to sell shares of our common stock in the public markets or in other registered offerings (subject to our securities trading policy and applicable securities law). As a result, we expect that these individuals, including each of our named executive officers, may sell, possibly in the near term, for personal financial planning and asset diversification purposes, shares of our common stock through block trades in negotiated transactions or by any other lawful methods permitted by applicable registration statements. As of September 13, 2010, the first date that these individuals may sell pursuant to our securities trading policy, our named executive officers and directors, who hold a substantial majority of these shares, will beneficially own approximately 1.5 million shares of our common stock.
60
61
62